Skip to main content
. 2026 May 30;25:171. doi: 10.1186/s12944-026-02984-5

Table 1.

Baseline characteristics of participants stratified by SCD status

All Non-SCD SCD P
N 3,172 3,098 74
Age, years 54.9 (45.8, 64.0) 54.2 (45.1, 63.9) 65.9 (57.7, 72.3) < 0.001
Male, n (%) 1,502 (47.4) 1,452 (46.9) 50 (67.6) < 0.001
Body mass index, kg/m2 23.2 (21.2, 25.6) 23.2 (21.2, 25.6) 23.0 (21.1, 25.6) 0.673
Systolic blood pressure, mmHg 120.0 (110.0, 138.0) 120.0 (110.0, 138.0) 129.0 (118.0, 148.0) 0.002
Diastolic blood pressure, mmHg 76.0 (70.0, 84.0) 76.0 (70.0, 84.0) 78.0 (70.0, 86.0) 0.291
Heart rate, beats/min 64.0 (58.0, 72.0) 64.0 (58.0, 72.0) 63.0 (56.0, 69.0) 0.090
Smoking, n (%) 1,173 (37.0) 1,132 (36.5) 41 (55.4) 0.001
Drinking, n (%) 951 (30.0) 926 (29.9) 25 (33.8) 0.521
Framingham risk score 13.0 (9.0, 15.0) 13.0 (9.0, 15.0) 15.0 (13.0, 18.0) < 0.001
Cardiovascular risk PROCAM score 40.0 (26.0, 51.0) 40.0 (26.0, 51.0) 52.0 (43.0, 60.0) < 0.001
Comorbidities, n (%)
 Prior atrial fibrillation 38 (1.2) 38 (1.2) 0 (0.0) 0.338
 Coronary artery disease 79 (2.5) 54 (1.7) 25 (33.8) < 0.001
 Diabetes mellitus 928 (29.3) 910 (29.4) 18 (24.3) 0.369
 Heart failure 26 (0.8) 25 (0.8) 1 (1.4) 0.460
 Cerebrovascular accident 144 (4.5) 140 (4.5) 4 (5.4) 0.577
 Hypertension 972 (30.6) 934 (30.1) 38 (51.4) < 0.001
 Chronic pulmonary disease 7 (0.2) 7 (0.2) 0 (0.0) 0.682
Medications, n (%)
 Hypertension medicine 378 (11.9) 356 (11.5) 22 (29.7) < 0.001
 Diabetes mellitus medicine 118 (3.7) 115 (3.7) 3 (4.1) 0.878
Electrocardiography parameters, n (%)
 LVH 258 (8.1) 239 (7.7) 19 (25.7) < 0.001
 RVH 8 (0.3) 7 (0.2) 1 (1.4) 0.056
 ST change 226 (7.1) 223 (7.2) 3 (4.1) 0.299
 Atrial premature contraction 32 (1.0) 27 (0.9) 5 (6.8) < 0.001
 Ventricular premature contraction 57 (1.8) 56 (1.8) 1 (1.4) 0.770
 Left bundle branch block 25 (0.8) 24 (0.8) 1 (1.4) 0.579
 Right bundle branch block 113 (3.6) 111 (3.6) 2 (2.7) 0.686
 Atrial fibrillation / atrial flutter 34 (1.1) 33 (1.1) 1 (1.4) 0.813
 Atrioventricular block 81 (2.6) 79 (2.6) 2 (2.7) 0.934
 Long QT 154 (4.9) 149 (4.8) 5 (6.8) 0.406
Laboratory results
 Fasting glucose, mg/dL 103.0 (96.0, 113.0) 103.0 (96.0, 113.0) 104.0 (96.0, 115.0) 0.466
 White blood cell, ×109/L 6.1 (5.1, 7.2) 6.1 (5.1, 7.2) 6.3 (5.3, 7.8) 0.289
 Lymphocyte, % 22.0 (18.0, 26.8) 22.0 (18.0, 26.0) 22.0 (16.0, 28.0) 0.865
 Platelet, ×109/L 262.0 (216.0, 313.0) 262.0 (216.0, 314.0) 249.0 (208.0, 296.0) 0.175
 Mean corpuscular volume, fL 93.5 (89.9, 96.8) 93.4 (89.9, 96.7) 95.1 (91.3, 98.8) 0.018
 Haemoglobin, g/dL 13.8 (12.8, 15.0) 13.8 (12.8, 15.0) 13.9 (12.9, 14.9) 0.857
 Albumin, g/L 4.6 (4.4, 4.9) 4.6 (4.4, 4.9) 4.5 (4.2, 4.9) 0.025
 Prealbumin, mg/L 26.5 (22.6, 31.2) 26.5 (22.6, 31.2) 26.8 (22.3, 31.7) 0.846
 eGFR, mL/min/1.73 m2 91.9 (74.3, 106.4) 92.3 (74.9, 106.5) 76.4 (64.5, 93.8) < 0.001
 Blood urea nitrogen, mg/dL 17.0 (14.0, 22.0) 17.0 (14.0, 22.0) 19.0 (16.0, 23.0) 0.001
 RDW, % 13.1 (12.7, 13.7) 13.1 (12.7, 13.7) 13.2 (12.7, 13.9) 0.199
 Transferrin, mg/dL 271.0 (243.3, 303.0) 272.0 (244.0, 303.0) 258.5 (227.0, 289.0) 0.014
 Triglycerides, mg/dL 100.0 (70.0, 150.0) 100.0 (70.0, 150.0) 103.5 (74.0, 161.0) 0.351
 Total cholesterol, mg/dL 194.0 (169.0, 225.0) 194.0 (169.0, 225.0) 204.0 (179.0, 244.0) 0.099
 HDL-C, mg/dL 46.0 (38.0, 55.0) 46.0 (38.0, 55.0) 43.5 (36.0, 55.0) 0.268
 LDL-C, mg/dL 135.0 (109.0, 165.0) 135.0 (109.0, 165.0) 141.5 (115.0, 182.0) 0.078
 Apolipoprotein A1, g/L 1.3 (1.1, 1.5) 1.3 (1.1, 1.5) 1.3 (1.1, 1.5) 0.239
 Apolipoprotein B, g/L 0.9 (0.7, 1.1) 0.9 (0.7, 1.1) 1.0 (0.8, 1.3) 0.023
 Lipoprotein(a), mg/L 92.7 (40.2, 194.5) 92.5 (40.2, 193.1) 111.6 (46.7, 234.0) 0.250

Abbreviations: eGFR estimated glomerular filtration rate, HDL-C high-density lipoprotein cholesterol, LDL-C low-density lipoprotein cholesterol, LVH left ventricular hypertrophy, RDW red cell distribution width, RVH right ventricular hypertrophy, SCD sudden cardiac death